Kinins IV pp 445-451 | Cite as

Michaelis-Menten Kinetics of Pulmonary Endothelial Angiotensin Converting Enzyme in the Conscious Rabbit

  • John D. Catravas
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 198A)


Estimations of Michaelis-Menten constants Km and Amax (product of Vmax and pulmonary microvascular plasma volume) of pulmonary, endothelial-bound angiotensin converting enzyme (ACE) for the synthetic substrate 3H-Benzoyl-Phe-Ala-Pro (BPAP) were performed in rabbits, in vivo, utilizing indicator dilution techniques. The animals were conscious and equipped with permanent right atrial and left carotid catheters. For each determination of Km and Amax, two consecutive bolus injections of BPAP were given into the right atrial catheter, the first containing 0.1 and the second 1622 nmol of substrate, producing first order and mixed order substrate concentrations, respectively, in the pulmonary circulation. Arterial blood was withdrawn at 0.7 sec intervals for 15 sec after each injection and from the family of substrate concentrations thus created (usually 14–20) and resulting range of substrate utilization (10–90%), Km and Amax values were calculated utilizing the Lineweaver-Burk, Eadie-Scatchard, Woolf-Augustinsson-Hofstee or Hanes-Woolf transformations of the integrated Henri-Michaelis-Menten equation. All four methods produced similar values of Km (10–12 μM), Amax (6–7 μmol/min) and Amax/Km (600–720 ml/min); however, linear regression analysis of data from the Hanes-Woolf transformation resulted in a higher correlation coefficient (0.96 vs 0.86-0.88 for the other three methods). Values for the kinetic constants reported here were similar to those previously reported in anesthetized rabbits utilizing the Woolf-Augustinsson-Hofstee transformation, but higher than those reported for purified rabbit lung ACE, in vitro.


Angiotensin Converting Enzyme Substrate Utilization Angiotensin Converting Enzyme Activity Serum Angiotensin Converting Enzyme Anesthetize Rabbit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. D. Catravas and R. E. White, Kinetics of angiotensin converting enzyme and 5-nucleotidase, in vivo, J. Appl. Physiol. 57: 1173–1181 (1984).PubMedGoogle Scholar
  2. 2.
    R. E. Howell, R. Moalli, and C. N. Gillis, Analysis of rabbit pulmonary angiotensin converting enzyme kinetics, in vivo, J. Pharmacol. Exp. Ther. 228: 154–160 (1984).PubMedGoogle Scholar
  3. 3.
    B. R. Pitt and G. Lister, Kinetics of pulmonary angiotensin converting enzyme activity in conscious developing lambs, J. Appl. Physiol. 57: 1158–1166 (1984).PubMedGoogle Scholar
  4. 4.
    J. H. Linehan and C. A. Dawson, A kinetic model of prostaglandin metabolism in the lung, J. Appl. Physiol. 47: 411–424 (1979).Google Scholar
  5. 5.
    I. H. Segal, “Enzyme Kinetics,” Wiley, New York (1975).Google Scholar
  6. 6.
    J. W. Ryan, L. C. Martin, A. Chung, and G. Pena, Mammalian inhibitors of angiotensin converting enzyme (Kininase II), Adv. Exp. Med. Biol. 120B: 599–606 (1979).Google Scholar
  7. 7.
    J. W. Ryan, Assay of peptidase and protease enzymes, in vivo, Biochem. Pharmacol. 32: 2127–2137 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    J. W. Ryan, Angiotensin I converting enzyme (Kininase II) peptidyl-dipeptide hydrolase EC, in: “Methods of Enzymatic Analysis, Vol. 5, ” H. O. Bergmeyer, ed., Verlag Chemie GmbH, Weinheim, Germany (1984).Google Scholar
  9. 9.
    J. S. Lazo, J. D. Catravas, and C. N. Gillis, Reduction in rabbit serum and pulmonary angiotensin converting enzyme activity after subacute bleomycin treatment, Biochem. Pharmacol. 18: 2577–2584 (1981).CrossRefGoogle Scholar
  10. 10.
    J. J. Lanzillo and B. L. Fanburg, Development of competitive enzyme immunoassays for human serum angiotensin-1-converting enzyme: A comparison of four assay configurations, Anal. Biochem. 126: 156–164 (1982).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • John D. Catravas
    • 1
  1. 1.Department of Pharmacology and ToxicologyMedical College of GeorgiaAugustaUSA

Personalised recommendations